Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 06:50:06 +0200Mon, 13 May 2024 10:36:00 +0200Human medicines European public assessment report (EPAR): Tresiba, insulin degludec, Date of authorisation: 20/01/2013, Revision: 17, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/tresibaHuman medicines European public assessment report (EPAR): Tresiba, insulin degludec, Date of authorisation: 20/01/2013, Revision: 17, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/tresibaMon, 13 May 2024 10:36:00 +0200Human medicineTresiba : EPAR - All Authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/ema-other-h-2498-en_1.pdfTresiba : EPAR - All Authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/ema-other-h-2498-en_1.pdfMon, 13 May 2024 02:00:00 +0200Human medicine